217 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Arcutis Competitors or Alternatives

Arcutis's top competitors include Dermavant, Incyte and Amgen.

Unlock 20 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Arcutis's company profile

Frank Watanabe

President & CEO

86/100
150
$896.8M
$196.5M
  • $896.8M
    $196.5M
  • 150
    $896.8M
  • $196.5M
  • 86/100
  • 150
  • $896.8M
  • $196.5M
View ProfileView
1
Arcutis's Competitor - Dermavant logo

Todd Zavodnick

CEO

90/100
100 - 250
$40M
$5M - 25M
  • $40M
    $5M - 25M
  • 100 - 250
    $40M
  • $5M - 25M
  • 90/100
  • 100 - 250
  • $40M
  • $5M - 25M
View ProfileView
2
Arcutis's Competitor - Incyte logo

Herve Hoppenot

President & CEO

74/100
2,320
- -
$4.2B
  • - -
    $4.2B
  • 2,320
    - -
  • $4.2B
  • 74/100
  • 2,320
  • - -
  • $4.2B
View ProfileView
3
Arcutis's Competitor - Amgen logo

Robert A. Bradway

Chairman & CEO

51/100
25,200
$4.1B
$33.4B
  • $4.1B
    $33.4B
  • 25,200
    $4.1B
  • $33.4B
  • 51/100
  • 25,200
  • $4.1B
  • $33.4B
View ProfileView
4
Arcutis's Competitor - Lilly logo

David A. Ricks

Chairman & CEO

80/100
39,000
- -
$45B
  • - -
    $45B
  • 39,000
    - -
  • $45B
  • 80/100
  • 39,000
  • - -
  • $45B
View ProfileView
5
Arcutis's Competitor - Pfizer logo

Albert Bourla

Chairman & CEO

69/100
83,000
$1B
$63.6B
  • $1B
    $63.6B
  • 83,000
    $1B
  • $63.6B
  • 69/100
  • 83,000
  • $1B
  • $63.6B
View ProfileView
Arcutis' top 23 competitors are Dermavant, Incyte, Amgen, AbbVie, Lilly, Pfizer, Bristol-Myers Squibb, Sandoz, Bausch Health, Regeneron, Dermira, Aclaris, Verrica, Dermata, Azitra, Orphagen Pharmaceuticals, Brinton, Zylo, Legacy Healthcare, Merz, Galderma, Allergan and Epirium Bio. Together they have raised over 45.5B between their estimated 315.6K employees. Arcutis has 150 employees and is ranked 16th among it's top 10 competitors. The top 10 competitors average 13,156.

Arcutis VS Dermavant

Dermavant is Arcutis's top competitor. Dermavant was founded in 2015 in Long Beach, California. Dermavant competes in the Biotechnology field. Dermavant generates $183.1M less revenue than Arcutis.

Arcutis VS Incyte

Incyte is perceived as one of Arcutis's biggest rivals. Incyte's headquarters is in Wilmington, Delaware, and was founded in 2002. Like Arcutis, Incyte also competes in the Pharmaceuticals industry. Incyte generates 2,157% of Arcutis's revenue.

Arcutis VS Amgen

Amgen is one of Arcutis's top competitors. Amgen is a Public company that was founded in Thousand Oaks, California in 1980. Like Arcutis, Amgen also competes in the Pharmaceuticals field. Amgen has 25,050 more employees vs. Arcutis.

Looking for similar companies to Arcutis?

Similar Companies

Pharmaceuticals & Biotechnology companies in Westlake Village

See 11 companies 
Companies in Westlake Village with employees in 250-500 range

See 15 companies 
Pharmaceuticals companies with revenue in $100-500M range

See 298 companies 
Pharmaceuticals companies with employees in 250-500 range

See 341 companies 
Pharmaceuticals companies in Los Angeles Metropolitan Area

See 485 companies 
Pharmaceuticals & Biotechnology companies with revenue in $100-500M range

See 569 companies 
Pharmaceuticals & Biotechnology companies with employees in 250-500 range

See 677 companies 
Companies in Los Angeles Metropolitan Area with revenue in $100-500M range

See 851 companies 
Pharmaceuticals & Biotechnology companies in Los Angeles Metropolitan Area

See 1,045 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Arcutis and Arcutis's Competitors

April 23, 2025FinanzNachrichten
Incyte (Nasdaq: INCY) today announced that multiple abstracts featuring new data from its oncology portfolio will be presented at the 2025 American Soc...
April 22, 2025Benzinga
read more...
April 23, 2025Benzinga
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. (NYS...
April 22, 2025FinanzNachrichten
Supplement In Response to Company Learning that Carl Icahn and Affiliates Have Cash-Settled Equity Swaps for Approximately 90 Million of Its Common Sha...
Today 9:58 AMFinSMEs
Grove Biopharma, a Chicago, IL-based private biotechnology company providing its Bionic Biologics platform, raised $30M in Series A funding...
April 23, 2025Benzinga
Bristol Myers' Cobenfy missed its primary endpoint in the Phase 3 ARISE trial but showed symptom improvement in certain subgroups. Latest Ratings for B...
April 23, 2025Pharmabiz
Fujifilm Diosynth Biotechnologies, a world─leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced the...
April 23, 2025Clinical Trials Arena
The US FDA has cleared the IND application of Aclaris to commence the placebo-controlled Phase Ia/Ib study of the ATI-052 antibody. The post Aclaris Th...
April 22, 2025The Center for Biosimilar
Sandoz's antitrust suit against Amgen, the FDA's interchangeability designation for Celltrion's adalimumab biosimilar, and the inclusion of an ustekinu...
April 23, 2025centralcharts
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 second-quarter 2025 dividend on the company's common stock, payabl...

Frequently Asked Questions about Arcutis

  1. Who are Arcutis's top competitors?

    Arcutis's top 3 competitors are Dermavant, Incyte, Amgen.

  2. Who is similar to Arcutis?

    Dermavant is the most similar to Arcutis. Incyte and Amgen are also similar to Arcutis.

  1. Are Arcutis and Dermavant competitors?

    Yes, Dermavant is one of Arcutis’s top competitors.